Tag: traumatic brain injury

November 1, 2017

PreveCeutical Receives Australian State Approval to Acquire and Use Cannabis as Part of Its Research and Development Program

PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") is pleased to announce that it has received approval (the...
September 20, 2017

International Stem Cell Moves Forward with Traumatic Brain Injury Phase II Clinical Trial

International Stem Cell announced the completion of its preclinical studies in Traumatic Brain Injury program will position it to commence...
September 13, 2017

Helius Medical Technologies Announces Extension of Agreement with US Army

Helius Medical Technologies announced its subsidiary NeuroHabilitation executed an extension to its research and development agreement with the US Army...
August 9, 2017

Scythian Biosciences Corp. Begins Trading on the TSXV under Symbol "SCYB"

Further to its press release dated August 2, 2017, Scythian Biosciences Corp. (the “Company” or “Scythian”, formerly Kitrinor Metals Inc., (TSXV:SCYB)...
May 18, 2017

Paul Gudonis, CEO of Myomo, Talks IPO Launch and its MyoPro International Potential

INN had the chance to speak with Paul Gudonis, CEO of Myomo, about its lead product and IPO launch.
April 5, 2017

International Stem Cell Posts 2016 Financial Report

International Stem Cell Corporation detailed their financial results for the fourth quarter and full year 2016 and provided a company...
February 17, 2017

Eyecarrot Innovations receives $149,990 in NRC funding

Eyecarrot Innovations Corp (TSXV:EYC) has been awarded up to $149,990 in funding by the National Research Council of Canada's industrial...